AngioDynamics, Inc. (ANGO) Balance Sheet
ANGO balance sheet, FY2026
May 31, 2026 · U.S. dollars$267.2M assets = $96.3M liabilities + $170.8M equity
Both columns are drawn to the same scale: what ANGO owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ANGO financial health
Descriptive bands, not a rating. Fiscal FY2026.
ANGO balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $708.0MFY2017 | $267.2MFY2026 | −10.3%/yr | |
| Total liabilities | $190.9MFY2017 | $96.3MFY2026 | −7.3%/yr | |
| Shareholders’ equity | $517.0MFY2017 | $170.8MFY2026 | −11.6%/yr | |
| Cash & short-term investments | $48.8MFY2017 | $53.9MFY2026 | +1.1%/yr | |
| Total debt | $105.9MFY2017 | $10.1MFY2025 | −25.4%/yr | |
| Net cash (debt) | −$57.2MFY2017 | $45.7MFY2025 | +$102.9M | |
| Working capital | $84.4MFY2017 | $88.7MFY2026 | +$4.3M | |
| Book value per share | $13.99FY2017 | $4.11FY2026 | −12.7%/yr | |
| Current ratio | 2.21FY2017 | 2.19FY2026 | −0.03 | |
| Debt / equity | 0.20FY2017 | 0.06FY2025 | −0.15 | |
| Shares outstanding | 37.0MFY2017 | 41.5MFY2026 | +1.3%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ANGO assets
ANGO liabilities and equity
ANGO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ANGO balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $53.9M | $55.9M | $76.1M | $44.6M | $28.8M | $48.2M | $54.4M | $227.6M | $75.4M | $48.8M |
| Cash & equivalents | $53.9M | $55.9M | $76.1M | $44.6M | $28.8M | $48.2M | $54.4M | $227.6M | $74.1M | $47.5M |
| Short-term investments | — | — | — | — | — | — | $689,000 | $0 | $1.3M | $1.2M |
| Receivables | $48.3M | $43.1M | $50.0M | $52.8M | $56.5M | $35.4M | $34.2M | $43.6M | $39.4M | $46.4M |
| Inventory | $52.4M | $62.0M | $60.6M | $55.3M | $51.4M | $48.6M | $59.9M | $40.1M | $39.3M | $54.5M |
| Other current assets | $8.8M | $7.3M | $6.6M | $10.8M | $6.6M | $8.7M | $4.4M | $4.0M | $13.9M | $4.3M |
| Total current assets | $163.4M | $168.3M | $193.3M | $163.5M | $143.3M | $140.9M | $152.9M | $315.3M | $168.0M | $153.9M |
| Property, plant & equipment (net) | $27.1M | $32.3M | $35.7M | $44.4M | $45.0M | $37.1M | $28.3M | $24.3M | $25.7M | $45.2M |
| Goodwill & intangible assets | $67.2M | $69.1M | $77.4M | $270.4M | $353.4M | $370.3M | $398.7M | $493.1M | $491.6M | $506.9M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $9.5M | $10.4M | $11.4M | $54.3M | $11.0M | $13.2M | $15.6M | $3.8M | $20.2M | $1.9M |
| Total assets | $267.2M | $280.1M | $317.7M | $532.6M | $552.8M | $561.4M | $595.5M | $836.4M | $705.5M | $708.0M |
| Liabilities | ||||||||||
| Accounts payable | $31.5M | $33.3M | $37.8M | $40.4M | $28.0M | $19.6M | $19.1M | $22.8M | $15.8M | $18.1M |
| Short-term debt | — | $2.2M | $4.7M | $14.8M | $8.8M | $2.4M | $836,000 | $12.1M | $7.1M | $14.6M |
| Deferred revenue | — | — | — | −$14.8M | $16.0M | −$2.4M | $29.5M | — | $32.3M | $27.2M |
| Total current liabilities | $74.7M | $76.2M | $91.2M | $83.8M | $74.3M | $57.6M | $51.5M | $73.3M | $57.3M | $69.5M |
| Long-term debt | $0 | $0 | $0 | $49.8M | $25.0M | $20.0M | $40.0M | $124.4M | $86.6M | $91.3M |
| Other long-term liabilities | $21.6M | $21.0M | $20.9M | $20.7M | $28.9M | $44.4M | $48.1M | $23.9M | $19.0M | $30.1M |
| Total liabilities | $96.3M | $97.2M | $112.1M | $154.3M | $128.3M | $122.0M | $139.6M | $221.6M | $162.9M | $190.9M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $387,000 | $385,000 | $385,000 | $382,000 | $380,000 | $377,000 | $374,000 | $372,000 | $370,000 | $367,000 |
| Retained earnings (deficit) | −$465.9M | −$429.2M | −$395.2M | −$210.9M | −$158.4M | −$131.9M | −$100.3M | $66.5M | $5.1M | −$11.0M |
| Treasury stock | — | — | — | −$5.7M | −$5.7M | −$5.7M | −$5.7M | −$5.7M | −$5.7M | −$5.7M |
| Accumulated other comprehensive income | $7.7M | −$2.0M | −$4.4M | −$4.7M | $1.4M | $3.2M | −$1.3M | −$1.4M | −$952,000 | −$1.3M |
| Minority interest | — | — | — | — | — | — | — | — | $0 | $0 |
| Total shareholders' equity | $170.8M | $183.0M | $205.6M | $378.3M | $424.5M | $439.5M | $455.9M | $614.8M | $542.6M | $517.0M |
| Key figures | ||||||||||
| Total debt | — | $10.1M | $4.7M | $64.6M | $33.8M | $22.4M | $40.8M | $136.5M | $93.7M | $105.9M |
| Net cash (debt) | — | $45.7M | $71.3M | −$20.0M | −$5.0M | $25.7M | $13.6M | $91.1M | −$18.3M | −$57.2M |
| Working capital | $88.7M | $92.1M | $102.1M | $79.7M | $69.0M | $83.3M | $101.4M | $242.0M | $110.7M | $84.4M |
| Tangible book value | $103.6M | $113.9M | $128.2M | $107.9M | $71.1M | $69.2M | $57.2M | $121.8M | $51.0M | $10.1M |
| Book value per share | $4.11 | $4.46 | $5.12 | $9.58 | $10.88 | $11.46 | $12.01 | $16.40 | $14.45 | $13.99 |
| Shares outstanding | 41.5M | 41.0M | 40.2M | 39.5M | 39.0M | 38.3M | 38.0M | 37.5M | 37.5M | 37.0M |
| Current ratio | 2.19 | 2.21 | 2.12 | 1.95 | 1.93 | 2.45 | 2.97 | 4.30 | 2.93 | 2.21 |
| Quick ratio | 1.37 | 1.30 | 1.38 | 1.16 | 1.15 | 1.45 | 1.72 | 3.70 | 2.00 | 1.37 |
| Debt / equity | — | 0.06 | 0.02 | 0.17 | 0.08 | 0.05 | 0.09 | 0.22 | 0.17 | 0.20 |
| Equity / assets | 63.9% | 65.3% | 64.7% | 71.0% | 76.8% | 78.3% | 76.6% | 73.5% | 76.9% | 73.0% |
| Aug '26 | May '26 | Feb '26 | Nov '25 | Aug '25 | May '25 | Feb '25 | Nov '24 | Aug '24 | May '24 | Feb '24 | Nov '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $34.0M | $53.9M | $37.8M | $41.6M | $38.8M | $55.9M | $44.8M | $54.1M | $55.0M | $76.1M | $78.5M | $60.9M |
| Cash & equivalents | $34.0M | $53.9M | $37.8M | $41.6M | $38.8M | $55.9M | $44.8M | $54.1M | $55.0M | $76.1M | $78.5M | $60.9M |
| Receivables | $44.9M | $48.3M | $45.6M | $44.4M | $42.6M | $43.1M | $49.0M | $43.2M | $39.6M | $50.0M | $49.5M | $51.6M |
| Inventory | $55.0M | $52.4M | $58.6M | $65.6M | $62.3M | $62.0M | $63.1M | $65.9M | $64.7M | $60.6M | $58.1M | $64.3M |
| Other current assets | $9.2M | $8.8M | $13.6M | $9.7M | $13.0M | $7.3M | $15.4M | $12.2M | $13.3M | $6.6M | $10.9M | $8.7M |
| Total current assets | $143.0M | $163.4M | $155.6M | $161.3M | $156.7M | $168.3M | $172.3M | $175.4M | $172.6M | $193.3M | $196.9M | $185.5M |
| Property, plant & equipment (net) | $27.7M | $27.1M | $29.1M | $30.5M | $31.1M | $32.3M | $32.5M | $33.0M | $34.4M | $35.7M | $37.0M | $42.6M |
| Goodwill & intangible assets | $61.9M | $67.2M | $65.5M | $66.7M | $68.4M | $69.1M | $70.9M | $73.1M | $75.8M | $77.4M | $81.6M | $263.1M |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $9.3M | $9.5M | $10.5M | $11.1M | $9.5M | $10.4M | $9.7M | $10.1M | $10.9M | $11.4M | $9.3M | $8.5M |
| Total assets | $241.9M | $267.2M | $260.7M | $269.7M | $265.6M | $280.1M | $285.4M | $291.6M | $293.6M | $317.7M | $324.8M | $499.6M |
| Liabilities | ||||||||||||
| Accounts payable | $26.6M | $31.5M | $29.1M | $35.4M | $31.9M | $33.3M | $30.3M | $34.7M | $31.3M | $37.8M | $35.2M | $37.6M |
| Short-term debt | $1.8M | — | $1.7M | $1.7M | $2.2M | $2.2M | $5.0M | $5.0M | $4.8M | $4.7M | $1.6M | $1.7M |
| Deferred revenue | — | — | — | — | — | — | — | — | $34.1M | — | — | −$1.7M |
| Total current liabilities | $59.7M | $74.7M | $66.1M | $72.0M | $68.3M | $76.2M | $78.0M | $88.6M | $76.7M | $91.2M | $85.9M | $78.0M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $18.3M | $21.6M | $21.3M | $21.4M | $18.5M | $21.0M | $21.6M | $16.2M | $20.3M | $20.9M | $20.3M | $20.4M |
| Total liabilities | $78.0M | $96.3M | $87.3M | $93.3M | $86.8M | $97.2M | $99.5M | $104.8M | $97.0M | $112.1M | $106.1M | $98.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $388,000 | $387,000 | $387,000 | $386,000 | $386,000 | $385,000 | $385,000 | $384,000 | $386,000 | $385,000 | $385,000 | $383,000 |
| Retained earnings (deficit) | −$473.0M | −$465.9M | −$454.5M | −$446.4M | −$440.1M | −$429.2M | −$423.1M | −$418.7M | −$408.0M | −$395.2M | −$381.8M | −$194.0M |
| Accumulated other comprehensive income | $4.7M | $7.7M | $2.7M | $998,000 | $61,000 | −$2.0M | −$3.5M | −$3.7M | −$3.3M | −$4.4M | −$2.8M | −$4.7M |
| Total shareholders' equity | $164.0M | $170.8M | $173.4M | $176.3M | $178.9M | $183.0M | $185.9M | $186.8M | $196.6M | $205.6M | $218.7M | $401.2M |
| Key figures | ||||||||||||
| Total debt | $10.7M | — | $11.4M | $11.8M | $9.6M | $10.1M | $5.0M | $5.0M | $4.8M | $4.7M | $4.0M | $4.2M |
| Net cash (debt) | $23.2M | — | $26.4M | $29.8M | $29.2M | $45.7M | $39.8M | $49.1M | $50.2M | $71.3M | $74.5M | $56.7M |
| Working capital | $83.3M | $88.7M | $89.5M | $89.4M | $88.4M | $92.1M | $94.3M | $86.8M | $95.9M | $102.1M | $111.0M | $107.4M |
| Tangible book value | $102.1M | $103.6M | $107.9M | $109.6M | $110.5M | $113.9M | $114.9M | $113.7M | $120.8M | $128.2M | $137.1M | $138.1M |
| Book value per share | $3.90 | $4.11 | $4.17 | $4.26 | $4.34 | $4.46 | $4.55 | $4.56 | $4.84 | $5.09 | $5.44 | $9.98 |
| Shares outstanding | 42.0M | 41.5M | 41.6M | 41.4M | 41.2M | 41.0M | 40.9M | 40.9M | 40.7M | 40.4M | 40.2M | 40.2M |
| Current ratio | 2.40 | 2.19 | 2.35 | 2.24 | 2.29 | 2.21 | 2.21 | 1.98 | 2.25 | 2.12 | 2.29 | 2.38 |
| Quick ratio | 1.32 | 1.37 | 1.26 | 1.20 | 1.19 | 1.30 | 1.20 | 1.10 | 1.23 | 1.38 | 1.49 | 1.44 |
| Debt / equity | 0.07 | — | 0.07 | 0.07 | 0.05 | 0.06 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 |
| Equity / assets | 67.8% | 63.9% | 66.5% | 65.4% | 67.3% | 65.3% | 65.1% | 64.1% | 66.9% | 64.7% | 67.3% | 80.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed July 14, 2026); data from EODHD.
ANGO financial position
At the end of fiscal 2026 (May 31, 2026), AngioDynamics had total assets of $267.2 million (down 4.6% from a year earlier), total liabilities of $96.3 million and shareholders' equity of $170.8 million. Its current ratio was 2.19. In the latest quarter (ended August 31, 2026) total assets were $241.9 million and equity $164.0 million.
Related: ANGO income statement, ANGO cash flow statement, ANGO key metrics. See the ANGO stock overview for the latest quote and news.
ANGO balance sheet FAQ
What are AngioDynamics's total assets?
AngioDynamics reported total assets of $267.2 million at the end of fiscal 2026 (May 31, 2026), compared with $280.1 million a year earlier.
How much cash does AngioDynamics have?
AngioDynamics held $53.9 million in cash and short-term investments at the end of fiscal 2026.
What is AngioDynamics's book value?
AngioDynamics's shareholders' equity (book value) was $170.8 million at the end of fiscal 2026, or $4.11 per share.
What is AngioDynamics's current ratio?
AngioDynamics had current assets of $163.4 million and current liabilities of $74.7 million, a current ratio of 2.19 (it can cover its short-term obligations).
How much goodwill does AngioDynamics have?
AngioDynamics carried $67.2 million of goodwill and intangible assets, 25.2% of total assets, at the end of fiscal 2026.